Kura Oncology
KURA
25 hedge funds and large institutions have $25.2M invested in Kura Oncology in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 2 closing their positions.
300% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 2
32% more funds holding
Funds holding: 19 → 25 (+6)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
39% less capital invested
Capital invested by funds: $41.4M → $25.2M (-$16.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
+$1.13M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$402K |
| 3 |
ACM
Alethea Capital Management
Mercer Island,
Washington
|
+$193K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$106K |
| 5 |
Renaissance Technologies
New York
|
+$41.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$2.96M |
| 2 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$992K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$875K |
| 4 |
BC
Birchview Capital
Burlington,
Vermont
|
-$62.2K |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$37.3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
26
Franklin Resources
San Mateo,
California
| – | -$2.96M | -730,500 | Closed |
|
27
UBS Group
Zurich,
Switzerland
| – | -$5K | -1,184 | Closed |
|
KURA Hedge Fund Activity: Q2 2016 in Review
25 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q2 2016, worth a combined $25.2M — down 39% from $41.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new KURA positions and 2 closed out — a net gain of 6 holders — while 6 added to existing stakes and 6 trimmed.
The largest buyer was Minerva Advisors, opening a new position worth an estimated $1.13M. The largest seller was Franklin Resources, exiting entirely with an estimated $2.96M sold.
- 25 institutional investors held Kura Oncology (KURA) as of Q2 2016, up from 19 in Q1 2016.
- Funds reported $25.2M of Kura Oncology stock for Q2 2016, down 39% quarter-over-quarter.
- 8 funds opened new Kura Oncology positions in Q2 2016 and 2 closed out, a net change of +6 holders.
- The largest Kura Oncology buyer in Q2 2016 was Minerva Advisors, an estimated $1.13M added.
- The largest Kura Oncology seller in Q2 2016 was Franklin Resources, an estimated $2.96M sold.
Based on aggregated 13F filings for Q2 2016.